FDA Adverse Event Malfunction Summary report: N

BIO-MEDICUS LIFE SUPPORT TM

MDR report key: 17105472 · Received June 12, 2023

Report

Report Number
2184009-2023-00483
Event Type
Malfunction
Date Received
June 12, 2023
Date of Event
May 25, 2023
Report Date
August 8, 2023
Manufacturer
MEDTRONIC MEXICO
Product Code
QHW
UDI-DI
00763000615420
PMA / PMN Number
K201057
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NL
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

CORRECTION B5: IT WAS REPORTED THAT THE CANNULA WAS INTENDED TO USE FOR EXTRA CORPOREAL LIFE SUPPORT (ECLS). DEVICE EVALUATION SUMMARY: VISUAL INSPECTION SHOWS EVIDENCE OF DAMAGE/CRACK IN THE CONNECTOR. REASON FOR RETURN WAS CONFIRMED. CONCLUSION: AFTER INVESTIGATION AT MEDTRONIC, THE COMPLAINT IS CONFIRMED FOR A CRACKED CANNULA BODY CONNECTOR. IT IS UNKNOWN WHAT MAY HAVE CAUSED THIS OCCURRENCE, HOWEVER, BASED ON THE AVAILABLE INFORMATION THIS COMPLAINT COULD BE THE RESULT OF A USE-RELATED ISSUE. THIS DAMAGE TO THE CANNULA CONNECTOR CAN OCCUR WHEN THE INTRODUCER IS INSERTED INTO THE CANNULA BODY WITHOUT THE USE OF THE HEMOSTASIS CAP. THE INTRODUCER HANDLE CAN CAUSE STRETCHING, CRAZING OR CRACKING WHEN IT IS FORCED INTO THE CONNECTOR. THE ISSUE IS MORE LIKELY TO OCCUR WITH THE ARTERIAL CANNULAE MODELS WITH A CLEAR HEMOSTASIS CAP THAT IS ATTACHED TO THE INTRODUCER ON THE PROVIDED CLEAR PROTECTIVE SHEATH. THE PHOTO PROVIDED BY THE CUSTOMER SHOWS THE INTRODUCER IS INSERTED INTO THE CANNULA CONNECTOR WITHOUT THE USE OF THE HEMOSTASIS CAP, THEREFORE, REVIEW OF THE DEVICE HISTORY RECORD WAS NOT COMPLETED BECAUSE THERE WAS NO EVIDENCE OF MANUFACTURING ISSUES WITH THE COMPLAINT PRODUCT. MANUFACTURING INVESTIGATION WAS COMPLETED FOR THIS FAILURE MODE. IN THIS INVESTIGATION THE MANUFACTURING PROCESS WAS REVIEWED, AND THE HANDLE OF THE AFFECTED PART IS MINIMUM, JUST PICK AND PLACE INTO THE PACKAGING, NO ADDITIONAL ASSEMBLY. REVIEW OF IN-PROCESS PICTURES SHOW THAT PIECES PRODUCED ARE IN GOOD CONDITION. PRODUCT EVENT NOTIFICATION AND AWARENESS WAS GIVEN TO THE PRODUCTION PERSONNEL ABOUT THE IMPLICATIONS AND CONSEQUENCES THAT REPORTED DEFECT HAS ON THE FIELD. THERE WERE NO ADVERSE PATIENT EFFECTS AS A RESULT OF THIS INCIDENCE. MEDTRONIC WILL CONTINUE TO MONITOR FOR FUTURE OCCURRENCES AND TRENDS. MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. ANY REQUIRED FIELDS THAT ARE UNPOPULATED ARE BLANK BECAUSE THE INFORMATION IS CURRENTLY UNKNOWN OR UNAVAILABLE. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Additional Manufacturer Narrative · 0

MEDTRONIC IS SUBMITTING THIS REPORT TO COMPLY WITH FDA REPORTING REGULATIONS UNDER 21 CFR PARTS 4 AND 803. THIS REPORT IS BASED UPON INFORMATION OBTAINED BY MEDTRONIC, WHICH THE COMPANY MAY NOT HAVE BEEN ABLE TO FULLY INVESTIGATE OR VERIFY PRIOR TO THE DATE THE REPORT WAS REQUIRED BY THE FDA. MEDTRONIC HAS MADE REASONABLE EFFORTS TO OBTAIN MORE COMPLETE INFORMATION AND HAS PROVIDED AS MUCH RELEVANT INFORMATION AS IS AVAILABLE TO THE COMPANY AS OF THE SUBMISSION DATE OF THIS REPORT. THIS REPORT DOES NOT CONSTITUTE AN ADMISSION OR A CONCLUSION BY FDA, MEDTRONIC, OR ITS EMPLOYEES THAT THE DEVICE, MEDTRONIC, OR ITS EMPLOYEE CAUSED OR CONTRIBUTED TO THE EVENT DESCRIBED IN THE REPORT. IN PARTICULAR, THIS REPORT DOES NOT CONSTITUTE AN ADMISSION BY ANYONE THAT THE PRODUCT DESCRIBED IN THIS REPORT HAS ANY ¿DEFECTS¿ OR HAS ¿MALFUNCTIONED¿. THESE WORDS ARE INCLUDED IN THE FDA 3500A FORM AND ARE FIXED ITEMS FOR SELECTION CREATED BY THE FDA TO CATEGORIZE THE TYPE OF EVENT SOLELY FOR THE PURPOSE OF REGULATORY REPORTING. MEDTRONIC OBJECTS TO THE USE OF THESE WORDS AND OTHERS LIKE THEM BECAUSE OF THE LACK OF DEFINITION AND THE CONNOTATIONS IMPLIED BY THESE TERMS. THIS STATEMENT SHOULD BE INCLUDED WITH ANY INFORMATION OR REPORT DISCLOSED TO THE PUBLIC UNDER THE FREEDOM OF INFORMATION ACT. A GOOD FAITH EFFORT WILL BE MADE TO OBTAIN THE APPLICABLE INFORMATION RELEVANT TO THE REPORT. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 0

MEDTRONIC RECEIVED INFORMATION THAT PRIOR TO USE OF A BIO-MEDICUS LIFE SUPPORT CANNULA, IT WAS REPORTED THE DEVICE HAD A DAMAGED CONNECTOR. THE DEVICE WAS REPLACED. THERE WAS NO PATIENT INVOLVEMENT, SO NO ADVERSE EFFECT OCCURRED. MEDTRONIC RECEIVED ADDITIONAL INFORMATION THAT THERE WAS NO DAMAGE WAS SEEN TO THE PACKAGING.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
267834 BIO-MEDICUS LIFE SUPPORT TM CATHETER, CANNULA AND TUBING, VASCULAR, CARDIO QHW MEDTRONIC MEXICO LS96218-017 225658503 00763000615420

Patients

Seq Age Sex Outcome Treatment
1 Unknown